Literature DB >> 24951284

Updates in diagnostic immunohistochemistry in endometrial carcinoma.

Sarah Chiang1, Robert A Soslow2.   

Abstract

Diagnostic difficulty in the morphologic assessment of endometrial carcinomas may arise in pathology practice. Challenges in tumor classification exist especially in the setting of high-grade carcinomas. These include FIGO grade 3 endometrioid, serous, clear cell, and undifferentiated carcinomas, in addition to carcinomas of mixed cell type and those exhibiting ambiguous morphologic features. This comprehensive review details key morphologic and immunophenotypic features of prototypic endometrial carcinomas, including a description of both well-established and novel immunohistochemical markers in the evaluation of these tumors. It also provides recommendations regarding prudent use of these ancillary techniques in distinguishing between various histologic subtypes of endometrial carcinoma that frequently result in persistent diagnostic problems.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Clear cell; Endometrial carcinoma; Endometrioid; Immunohistochemistry; Serous; Undifferentiated

Mesh:

Substances:

Year:  2014        PMID: 24951284     DOI: 10.1053/j.semdp.2014.03.002

Source DB:  PubMed          Journal:  Semin Diagn Pathol        ISSN: 0740-2570            Impact factor:   3.464


  5 in total

1.  Are the uterine serous carcinomas underdiagnosed? Histomorphologic and immunohistochemical correlates and clinical follow up in high-grade endometrial carcinomas initially diagnosed as high-grade endometrioid carcinoma.

Authors:  Shaomin Hu; Jeff L Hinson; Rahul Matnani; Michael L Cibull; Rouzan G Karabakhtsian
Journal:  Mod Pathol       Date:  2017-10-06       Impact factor: 7.842

2.  TP53 Mutational Spectrum in Endometrioid and Serous Endometrial Cancers.

Authors:  Anne M Schultheis; Luciano G Martelotto; Maria R De Filippo; Salvatore Piscuglio; Charlotte K Y Ng; Yaser R Hussein; Jorge S Reis-Filho; Robert A Soslow; Britta Weigelt
Journal:  Int J Gynecol Pathol       Date:  2016-07       Impact factor: 2.762

Review 3.  Metabolomics for Diagnosis and Prognosis of Uterine Diseases? A Systematic Review.

Authors:  Janina Tokarz; Jerzy Adamski; Tea Lanišnik Rižner
Journal:  J Pers Med       Date:  2020-12-21

4.  Immunohistochemical expression of hormone receptors, Ki-67, endoglin (CD105), claudins 3 and 4, MMP-2 and -9 in endometrial polyps and endometrial cancer type I.

Authors:  Gustavo Filipov Peres; Daniel Spadoto-Dias; Flávia Neves Bueloni-Dias; Nilton José Leite; Leonardo Vieira Elias; Maria Aparecida Custódio Domingues; Carlos Roberto Padovani; Rogério Dias
Journal:  Onco Targets Ther       Date:  2018-07-09       Impact factor: 4.147

5.  Survival implication of lymphadenectomy in patients surgically treated for apparent early-stage uterine serous carcinoma.

Authors:  Jvan Casarin; Giorgio Bogani; Elisa Piovano; Francesca Falcone; Federico Ferrari; Franco Odicino; Andrea Puppo; Ferdinando Bonfiglio; Nicoletta Donadello; Ciro Pinelli; Antonio Simone Laganà; Antonino Ditto; Mario Malzoni; Stefano Greggi; Francesco Raspagliesi; Fabio Ghezzi
Journal:  J Gynecol Oncol       Date:  2020-09       Impact factor: 4.401

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.